Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
暂无分享，去创建一个
A. Jimeno | P. Harari | C. Nutting | D. Rischin | L. Wirth | J. Vermorken | D. Cernea | A. Pirzkall | J. Fayette | T. Csoszi | E. Penuel | W. Hanley | A. Udrea | A. Kapp | C. Oprean | B. McCall | Maria Anderson | P. O'brien | T. Csőszi